Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates in high-activity natural killer immunotherapy for small metastases of melanoma (Phase 1/Phase 2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED